4//SEC Filing
Davit Paul Stephen 4
Accession 0000930413-10-001908
CIK 0000727510other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 8:53 PM ET
Size
9.3 KB
Accession
0000930413-10-001908
Insider Transaction Report
Form 4
Davit Paul Stephen
Exec. Vice Pres. HR
Transactions
- Exercise/Conversion
Restricted Stock Units
2010-04-03−9,570→ 12,760 totalExercise: $0.00From: 2010-04-03Exp: 2010-04-03→ Common Stock (9,570 underlying) - Exercise/Conversion
Common Stock
2010-04-03+9,570→ 93,335.165 total - Tax Payment
Common Stock
2010-04-03$10.48/sh−2,826$29,616→ 90,509.165 total
Footnotes (3)
- [F1]Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock.
- [F2]The Reporting Person's beneficial ownership includes an aggregate of 1,241 shares of Common Stock purchased during the six months ended March 31, 2009 pursuant to the Issuer's 2007 Employee Stock Purchase Plan, which is exempt under Rule 16b-3(c).
- [F3]The Reporting Person used the proceeds of the disposition solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001323791
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 8:53 PM ET
- Size
- 9.3 KB